S Ericsson

1.1k total citations
24 papers, 958 citations indexed

About

S Ericsson is a scholar working on Surgery, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, S Ericsson has authored 24 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Oncology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in S Ericsson's work include Drug Transport and Resistance Mechanisms (8 papers), Lipoproteins and Cardiovascular Health (8 papers) and Cancer, Lipids, and Metabolism (5 papers). S Ericsson is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Lipoproteins and Cardiovascular Health (8 papers) and Cancer, Lipids, and Metabolism (5 papers). S Ericsson collaborates with scholars based in Sweden, United States and Italy. S Ericsson's co-authors include Bo Angelin, Lars Berglund, Kurt Einarsson, Mats Eriksson, Sigurd Vitols, Mats Rudling, Gösta Eggertsen, B. Angelin, S Ewerth and H. Olivecrona and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

S Ericsson

24 papers receiving 908 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Ericsson Sweden 15 461 299 209 178 172 24 958
Shoichi Katayama Japan 18 331 0.7× 550 1.8× 130 0.6× 168 0.9× 124 0.7× 34 1.1k
Wijtske Annema Netherlands 23 705 1.5× 631 2.1× 233 1.1× 349 2.0× 185 1.1× 37 1.6k
Dorota Diakowska Poland 21 347 0.8× 188 0.6× 188 0.9× 366 2.1× 368 2.1× 92 1.3k
B. Parada Portugal 18 398 0.9× 138 0.5× 69 0.3× 168 0.9× 148 0.9× 74 1.1k
F. A. Wenger Germany 20 1.0k 2.2× 432 1.4× 280 1.3× 152 0.9× 432 2.5× 60 1.6k
Yunfei Liao China 19 168 0.4× 253 0.8× 130 0.6× 403 2.3× 232 1.3× 79 1.2k
Jin‐Zhen Wu China 23 468 1.0× 392 1.3× 168 0.8× 395 2.2× 77 0.4× 68 1.4k
Yasushi Imamura Japan 19 220 0.5× 158 0.5× 92 0.4× 335 1.9× 88 0.5× 51 1.3k
Haozhu Chen China 16 253 0.5× 197 0.7× 88 0.4× 217 1.2× 64 0.4× 50 928
Po‐Yuan Chang Taiwan 21 284 0.6× 124 0.4× 84 0.4× 329 1.8× 64 0.4× 43 1.0k

Countries citing papers authored by S Ericsson

Since Specialization
Citations

This map shows the geographic impact of S Ericsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Ericsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Ericsson more than expected).

Fields of papers citing papers by S Ericsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Ericsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Ericsson. The network helps show where S Ericsson may publish in the future.

Co-authorship network of co-authors of S Ericsson

This figure shows the co-authorship network connecting the top 25 collaborators of S Ericsson. A scholar is included among the top collaborators of S Ericsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Ericsson. S Ericsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lind, Suzanne, Mats Rudling, S Ericsson, et al.. (2003). Growth Hormone Induces Low-Density Lipoprotein Clearance but not Bile Acid Synthesis in Humans. Arteriosclerosis Thrombosis and Vascular Biology. 24(2). 349–356. 38 indexed citations
2.
Ericsson, S, Lars Berglund, Johan Frostegård, Kurt Einarsson, & Bo Angelin. (1997). The influence of age on low density lipoprotein metabolism: effects of cholestyramine treatment in young and old healthy male subjects. Journal of Internal Medicine. 242(4). 329–337. 21 indexed citations
3.
Stenvinkel, Peter, Lars Berglund, S Ericsson, et al.. (1997). Low‐density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome. European Journal of Clinical Investigation. 27(2). 169–177. 15 indexed citations
4.
Olivecrona, H., S Ericsson, & B Angelin. (1995). Growth hormone treatment does not alter biliary lipid metabolism in healthy adult men.. The Journal of Clinical Endocrinology & Metabolism. 80(4). 1113–1117. 17 indexed citations
5.
Olivecrona, H., S Ericsson, Lars Berglund, & B Angelin. (1993). Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment.. BMJ. 306(6894). 1726.2–1727. 59 indexed citations
6.
Eggertsen, Gösta, et al.. (1993). Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clinical Chemistry. 39(10). 2125–2129. 123 indexed citations
7.
Angelin, Bo, Herbert Olivecrona, S Ericsson, & Mats Rudling. (1993). Growth hormone and low-density lipoproteins.. PubMed. 128 Suppl 2. 26–8. 9 indexed citations
8.
Ericsson, S, Mats Eriksson, Lars Berglund, & Bo Angelin. (1992). Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy. Journal of Internal Medicine. 232(4). 313–320. 6 indexed citations
9.
Angelin, Bo, et al.. (1992). Effects of growth hormone on low-density lipoprotein metabolism.. PubMed. 383. 67–8; discussion 69. 8 indexed citations
10.
Ericsson, S, et al.. (1991). Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test.. Gut. 32(9). 1044–1048. 35 indexed citations
11.
Ericsson, S, et al.. (1991). Gemfibrozil in familial combined hyperlipidaemia: effect of added low‐dose cholestyramine on plasma and biliary lipids. European Journal of Clinical Investigation. 21(3). 344–349. 12 indexed citations
12.
Carrella, M., et al.. (1991). Effect of cholestyramine treatment on biliary lipid secretion rates in normolipidaemic men. Journal of Internal Medicine. 229(3). 241–246. 15 indexed citations
13.
Ericsson, S, Mats Eriksson, Sigurd Vitols, et al.. (1991). Influence of age on the metabolism of plasma low density lipoproteins in healthy males.. Journal of Clinical Investigation. 87(2). 591–596. 125 indexed citations
14.
Einarsson, Kurt, et al.. (1991). Bile acid sequestrants: Mechanisms of action on bile acid and cholesterol metabolism. European Journal of Clinical Pharmacology. 40(1). S53–S58. 31 indexed citations
15.
Eriksson, Maria, B. Angelin, Peter Henriksson, et al.. (1991). Metabolism of lipoprotein remnants in humans. Studies during intestinal infusion of fat and cholesterol in subjects with varying expression of the low density lipoprotein receptor.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 11(4). 827–837. 32 indexed citations
16.
Ericsson, S, Mats Eriksson, & Bo Angelin. (1990). Biliary lipids in familial combined hyperlipidaemia: effects of acipimox therapy. European Journal of Clinical Investigation. 20(3). 261–265. 6 indexed citations
17.
Henriksson, Peter, S Ericsson, Reinhard Stege, et al.. (1989). HYPOCHOLESTEROLAEMIA AND INCREASED ELIMINATION OF LOW-DENSITY LIPOPROTEINS IN METASTATIC CANCER OF THE PROSTATE. The Lancet. 334(8673). 1178–1180. 67 indexed citations
18.
Ericsson, S & H Gnarpe. (1978). Lymecycline or doxycycline for treatment of urinary-tract infections: a comparison of attained urine concentrations.. PubMed. 20(80). 95–8. 6 indexed citations
19.
Ericsson, S. (1977). Cariostatic Mechanisms of Fluorides: Clinical Observations (Part 2 of 2). Caries Research. 11(1). 23–41. 2 indexed citations
20.
Ericsson, S. (1977). Cariostatic Mechanisms of Fluorides: Clinical Observations. Caries Research. 11(1). 2–41. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoichi Katayama Breakdown of academic impact, for papers by Wijtske Annema Breakdown of academic impact, for papers by Dorota Diakowska Breakdown of academic impact, for papers by B. Parada Breakdown of academic impact, for papers by F. A. Wenger Breakdown of academic impact, for papers by Yunfei Liao Breakdown of academic impact, for papers by Jin‐Zhen Wu Breakdown of academic impact, for papers by Yasushi Imamura Breakdown of academic impact, for papers by Haozhu Chen Breakdown of academic impact, for papers by Po‐Yuan Chang
Rankless by CCL
2026